Welcome to Gaia! ::

Stoner Hangout: A Discussion/Talk about Marijuana/Drugs/Life

Back to Guilds

 

 

Reply Guides/Factual Information
Phenelyamines

Quick Reply

Enter both words below, separated by a space:

Can't read the text? Click here

Submit

RaveKitten13

PostPosted: Sun Aug 20, 2006 8:12 pm


I'll link to them nicer.

The drugs will have their info, then a trip report post following.

MD**
AMT
The 2Cs

(more to come)
PostPosted: Sun Aug 20, 2006 8:14 pm


This family includes the following substances (informations from erowid.org and PiHKAL):

MDA (3,4-Methylenedioxyamphtamine): MDA is a synthetic empathogen sometimes found in ecstasy tablets. It is closely related to MDMA though its effects are said to be slightly more psychedelic.

MDE (MDEA, Eve, N-Ethyl-MDA, 3,4-Methylenedioxy-N-Ethylamphetamine):MDE is a synthetic empathogen sometimes found in ecstasy tablets. It is closely related to MDMA though its effects are said to be milder and less stimulating.

MDMA (MDM, Adam, Ecstasy, 3,4-Methylendioxy-N-Methylamphetamine):MDMA (ectasy) is classified as a euphoric empathogen, phenethylamine, and stimulant. It is scheduled as a hallucinogen with other psychedelics. It has been used to treat PTSD (post traumatic stress disorder) and MAPS (maps.org) is working on trying to get it legal for that use again (also working with getting other psychedelics into the medicinal market).

MDMC (EDMA, 3,4-Ethylendioxy-N-Methylamphetamine): MDMA like but no psychedelic indicators.

MDMP (alpha,alpha,N-Trimethyl-3,4-Methylendioxy-phenethylamine, Methylenedioxymephentermine): Possible MDMDA substitute. Not psychedelic at moderate levels but might evolve more like MDMA at a higher dose.

MDOH (N-hydroxy-MDA, 3,4-Methylenedioxy-N-Hydroxyamphetamine): Nearly identical to MDA.

MDPH (alpha,alpha-Dimethyl-3,4-Methylendioxy-Phenethylamine, 3,4-methylenedioxyphentermine): similar to MDA.

Dec 24, 1912 MDMA patented by Merck Pharmaceuticals.

1953 The Army Chemical Center studied MDMA toxicity by giving MDMA to guinea pigs, rats, mice, monkeys, and dogs. It is determined to be less toxic than MDA.

1965 Alexander Shulgin synthesizes MDMA but does not yet try it.

c. 1967 The first small underground batches of MDMA are synthesized. Relatively few individuals have tried it at this point.

c. 1968 Alexander Shulgin begins working with MDMA personally and introducing others to it.

Aug 1970 First published case report of recreational MDMA use.

1976 The first scholarly article on MDMA is published.

c. 1977 MDMA begins to be available on the street as a recreational drug.

1977 Great Britain amended its Misuse of Drugs Act (1971) to include as Class A all compounds structurally derived from an N-alkyl-alpha-methylphenethylamine by substitution in the ring with an alkylendioxy substituent. This legislation encompassed all ring substituted amphetamines (including MDA, MDE, MDMA, etc). Class A is the most controlled category of drugs in Britain.

1977 - 1981 Only eight individuals seek emergency room treatment after the use of MDMA during this four year period according to the Drug Abuse Warning Network (DAWN).

1981 - 1985 There are zero people who seek emergency room treatment after the use of MDMA during this four year period, according to the Drug Abuse Warning Network (DAWN).

Jul 1, 1985 MDMA temporarily placed into Schedule I by the DEA under emergency scheduling provisions.

1987 First published report of a human death due to MDMA use.

Dec 22, 1987 MDMA is removed from schedule I because of improper procedure in its original emergency scheduling by the DEA.

Mar 23, 1988 MDMA permanently placed in Schedule I.

Mar 23, 1988 MDMA is placed back into Schedule I without challenge.

1991 Alexander and Ann Shulgin publish PiHKAL, documenting over 250 phenethylamines, including MDMA, mescaline, 2C-B, 2C-T-7, 2C-T-2, and many others.

1994-1999 During this 5 year period, there were 27 Ecstasy-related deaths in the U.S. as reported by SAMSA

2000 - 2001 Nearly 20 deaths around the world are attributed to tablets containing PMA sold as Ecstasy.

http://www.erowid.org/chemicals/mdma/mdma_timeline.php

Pills not containing MDMA may be sold as E. Testing kits (http://www.erowid.org/chemicals/mdma/mdma_faq_testing_kits.shtml) are highly recomended to make sure you are getting the proper drug.

Price:
$10-25 on average per tab at a rave (can reach up to $50). Large quanities can sell for $100-250 pre gram (~$10-25 per dose).

Substance:
MDMA, Ecstacy, X, E, XCT, M, adam, bean, roll

Experience:
rolling, tripping, X-ing, wigging

Addiction Potential
MDMA has the potential to be psychologically addicting. Individuals who use it regularly may find they have an increased desire to continue using it. There is a short period of tolerance after MDMA use. Using MDMA two days in a row is likely to lead to a greatly diminished experience the second day, though spaced 7 or more days apart, this effect is lessened. Some users report noticing reduced effects for up to 2 or 3 weeks after initial use.

"Loss of Magic"
Many users report that their enjoyment of MDMA seems to decrease as total lifetime usage increases. Some users report that E 'loses its magic' with as few as 10 experiences, while others have reported hundreds of uses before the empathic qualities fades or disappears. (generally recommended even through recreational users to take 6 weeks between each use)

Increased Negative Effects
Most users stop taking E because of either an increased awareness or an actual increase in negative side effects during use, a reduced quality of the high, and increases in the post-MDMA depression and day after hangover.

Increasing Dosage
Most users report that when using more than once a month, or merely over increased total lifetime use, they need to increase the dosage in order to get positive effects with MDMA. Increased dosage is associated with increased side effects, hangover, and week-after depression.

Neurotoxicity
There is an ongoing debate about the possible neurotoxicity of MDMA. Most experts now agree that MDMA is neurotoxic, but there is little agreement on what the consequences of this toxicity are. Alcohol is also a neurotoxin, for instance, as are many other medications. There is some evidence of changes to the brain in those who use MDMA heavily and/or frequently and a few studies have shown reductions in memory & increases in depression and anxiety, but these studies have not been completely verified and debate continues. This is a very complicated issue. (good way to avoid this possibility is no more than 4 uses a year and 30-35 uses in your life)

Contraindications

Do not take MDMA if you are currently taking an MAOI. MAOIs are most commonly found in the prescription anti-depressants Nardil (phenelzine), Parnate (tranylcypromine), Marplan (isocarboxazid), Eldepryl (l-deprenyl), and Aurorex or Manerix (moclobemide). Ayahuasca also contains MAOIs (harmine and harmaline). MDMA and MAOIs are a potentially dangerous combination. Check with your doctor if you are not sure whether your prescription medication is an MAOI.


Avoid taking MDMA if you are currently using the protease inhibitor Ritonavir. This may be a life-threatening combination.


Individuals with a history of heart ailments, high blood pressure, aneurysm or stroke, glaucoma, hepatic (liver) or renal (kidney) disorders, or hypoglycemia may be at higher risk.


Avoid strong stimulants in combination with MDMA.


Avoid high doses and frequent use. Recent studies suggest that the heavier and more frequent the use, the more concerning the long term after-effects may be.


A small percentage (1-10% depending on race & family history) are "slow metabolizers", who have low levels of a liver enzyme (P450 2D6) which metabolizes many drugs, including MDMA (as well as Prozac, DXM, and many other pharmaceuticals). These people may be more sensitive to MDMA, might require lower doses, and should be cautious.

http://www.erowid.org/chemicals/mdma/mdma_basics.shtml






MDMA

EFFECTS
POSITIVE
extreme mood lift
increased willingness to communicate
increase in energy (stimulation) Stimulant quality
ego softening
feelings of comfort, belonging, and closeness to others
feelings of love and empathy
forgiveness
increased awareness & appreciation of music
increased awareness of senses. (eating, drinking, smell) present in most psychedelics
profound life-changing spiritual experiences present in most psychedelics
neurotically based fear dissolution
sensations bright and intense
urge to hug and kiss people

NEUTRAL
appetite loss
visual distortion
rapid, involuntary eye jiggling (nystagmus)
mild visual hallucinations (uncommon) present in most psychedelics
moderately increased heart rate and blood pressure (increases with dose)
restlessness, nervousness, shivering
change in body temperature regulation
upwellings of unexpected emotion, emotional lability
strong desire to do or want more when coming down

NEGATIVE
(negative side effects increase with higher doses and frequent use)

inappropriate and/or unintended emotional bonding
tendency to say things you might feel uncomfortable about later
mild to extreme jaw clenching (trisma), tongue and cheek chewing, and teeth grinding (bruxia)
difficulty concentrating & problems with activities requiring linear focus
short-term memory scramble or loss & confusion
muscle tension
erectile disfunction and difficulty reaching orgasm
increase in body temperature, hyperthermia, dehydration (drink water)
hyponatremia (don't drink too much water)
nausea and vomiting
headaches, dizziness, loss of balance, and vertigo
sadness on coming down, sense of loss or immediate nostalgia
post-trip Crash - unpleasantly harsh comedown from the peak effect
hangover the next day, lasting days to weeks
mild depression and fatigue for up to a week
severe depression and/or fatigue (uncommon)
possible strong urge to repeat the experience, though not physically addictive
possible psychological crisis requiring hospitalization (psychotic episodes, severe panic attacks, etc) (rare)
possible liver toxicity (rare)
possible neurotoxicity (controversial)
small risk of death. Approximately 2 per 100,000 users have extreme negative reactions resulting in death. (rare)


http://www.erowid.org/chemicals/mdma/mdma_effects.shtml

MDA

POSITIVE
extreme mood lift
increased willingness to communicate
increase in energy (stimulation)
ego softening
feelings of comfort, belonging, and closeness to others
feelings of love and empathy
forgiveness
increased awareness & appreciation of music
increased awareness of senses. (eating, drinking, smell)
profound life-changing spiritual experiences
neurotically based fear dissolution
sensations bright and intense
urge to hug and kiss people
NEUTRAL
appetite loss
visual distortion
rapid, involuntary eye jiggling (nystagmus)
mild visual hallucinations
moderately increased heart rate and blood pressure (increases with dose)
restlessness, nervousness, shivering
change in body temperature regulation
strong desire to do or want more when coming down
NEGATIVE
(negative side effects increase with higher doses and frequent use)

inappropriate and/or unintended emotional bonding
tendency to say things you might feel uncomfortable about later
mild to extreme jaw clenching (trisma), tongue and cheek chewing, and teeth grinding (bruxia)
difficulty concentrating & problems with activities requiring linear focus
short-term memory scramble or loss & confusion
muscle tension
erectile disfunction and difficulty reaching orgasm
increase in body temperature, hyperthermia, dehydration (drink water)
hyponatremia (don't drink too much water)
nausea and vomiting
headaches, dizziness, loss of balance, and vertigo
post-trip Crash - unpleasantly harsh comedown from the peak effect
hangover the next day, lasting days to weeks
mild depression and fatigue for up to a week
severe depression and/or fatigue (uncommon)
possible strong urge to repeat the experience, though not physically addictive
possible psychological crisis requiring hospitalization (psychotic episodes, severe panic attacks, etc) (rare)
possible liver toxicity (rare)
possible neurotoxicity (controversial)
small risk of death. Assuming similar risk to MDMA, approximately 2 per 100,000 users have extreme negative reactions resulting in death. (rare)

http://www.erowid.org/chemicals/mda/mda_effects.shtml

DOSE

MDMA:
Common for small or sensitive people 50 - 75 mg
Common for most people 75 - 125 mg
Common for large or unsensitive people 125 - 175 mg
Required by few (side effects increase) 200 + mg

Duration: 3 - 5 hours
After Effects: up to 24 hours (personal experience: taking a Xanax to help with pain MAY put you back on the roll, did to me).

http://www.erowid.org/chemicals/mdma/mdma_dose.shtml

Usually taken orally, MDMA may be snorted or plugged (inserted by the rectum).

MDA:

Threshold 30 - 50 mg
Common for small or sensitive people 75 - 100 mg
Common for most people 100 - 150 mg
Common for large or unsensitive people 130 - 170 mg
Required by few (side effects increase) 170 + mg


Onset : 20 - 90 minutes (depending on form and stomach contents)
Duration : 2 - 5 hours
Normal After Effects : 2 - 4 hours

MDE:

Threshold 30 - 50 mg
Common for small or sensitive people 80 - 120 mg
Common for most people 120 - 150 mg
Common for large or unsensitive people 150 - 200 mg
Required by few (side effects increase) 200 + mg


Duration : 2 - 4 hours
Normal After Effects : 3 - 6 hours

MDMC:

200+ mg
Duration: 3-5 hours

MDMP:

110+ mg
Duration:6 hours

MDOP:

100-160mg
Duration: 3-6 hours

MDPH:

160-240 mg
Duration: 3-5 hours

LAW
MDMA:

USA
Schedule I: Illegal to use, own, buy, or sell w/o DEA liscense.
BELGIUM
Illegal
CANADA
Requires perscription to own or use.
EGYPT
Requires perscription to own or use.
UK
Class A (illegal). Might be moving to class B
NEW ZEALAND
Controlled class B2. Might be moved to stronger control in class B1.

http://www.erowid.org/chemicals/mdma/mdma_law.shtml

MDA:
USA: Same as MDMA

New Zealand
MDA is Schedule I (Class A) in New Zealand [reference]. (Thanks BC)
U.K.
MDA is Schedule I/Class A in the U.K., making it illegal to sell, buy, or possess without a license.

MDE:

USA: same as MDMA

U.K.
MDE is Schedule I/Class A in the U.K., making it illegal to sell, buy, or possess without a license.

No information on the legal status on the rest of the family. Probably considered illegal due to the analoge act.

Reported deaths or injuries of people with MD* in their system. http://thedea.org/morgue.html

1. Person taking 1200 mg of MDA AFTER a 300 mg tablet of methaqualone. Believed the mixture was LSD, morphine and amphetamine.

2. Person falls from a ultility tower onto a power line. Not sure if fall or shock killed them. Strange to have happened on MDMA because it tends to produce a paranioa of dangerous activities.

3. Asthmatic person consuming twice the normal dose for an effect to occur.

4. Not a death. Breakdowns from a person using 4-7 times a week for past four months.

5. MDMA+Alcohol+car surfing=BAD IDEA.

6. Person driving sans seatbelt with 4-5 times the peak dose in his system. Crash probably would have been survivable with the seatbelt.

7. Not MDA or MDE or MDMA.

8. Dancing for 8 hours while blowing on a whistle.

9. suicide attempt on MDMA

10. Suicide attempt on MDMA AND alcohol.

11. Successful suicide on MDMA (body temp reach 107)

RaveKitten13


RaveKitten13

PostPosted: Sun Aug 20, 2006 8:17 pm


Generally a person is told their first roll is the best roll. My first roll (NYE) was amazing yes, but Saturday I had my second roll and that just blew the first one out of the water.

Good a** s**t, I sounded like a broken record with the word amazing. Rolled with my new boyfriend (and yes in a situation like that sex is possible and that was the best sex ever, of course the sex non rolling have been mindblowing too... but they haven't come too close to the roll sex) and it just left me in a state of bliss
PostPosted: Sun Aug 20, 2006 8:19 pm


Formed in the 1960s and was uncommon until the 1990s and the rave scene. In Russia was used as an anti depressant (an MAOI do not use with MDMA or DXM). Made illegal in the states in April 2003.

http://www.erowid.org/chemicals/amt/amt.shtml

Price:
$5-12 at events $100-150 per gram from chemical suppliers
Names:
Alpha-Methyl, IT-290
Experience:
Tripping

http://www.erowid.org/chemicals/amt/amt_basics.shtml

EFFECTS

POSITIVE
increase in energy (stimulation)
mood lift, smiling
visual patterning and closed eye visuals
increased awareness & appreciation of music
empathogenic qualities

NEUTRAL
general change in consciousness (as with most psychoactives)
blurred vision
restlessness
yawning
dilated pupils

NEGATIVE
anxiety, tension
nausea and vomiting
decrease in coordination
muscle aching
headaches
jaw clenching (trisma)

http://www.erowid.org/chemicals/amt/amt_effects.shtml

DOSE

Oral
Light 10-25 mg
Common 20-40
Strong 30-60
Heavy 60-80

10-14 hour duration

Smoked
Light 4 - 5 mg
Common 6 - 10 mg
Strong 10 - 20 mg

8-12 hour duration

http://www.erowid.org/chemicals/amt/amt_dose.shtml

Schedule 1 drug. Illegal to posses, buy, use, or sell without DEA liscense.
Scehdule 8 (very controlled) in Australia
Illegal in Germany with other psychedelics
Controlled in Greece
Controlled in Japan
Controlled in Sweden
Not controlled nor subsituted in UK

http://www.erowid.org/chemicals/amt/amt_law.shtml






CAUTION!

There have been deaths reported from this drug.

http://www.erowid.org/chemicals/amt/amt_death1.shtml

RaveKitten13


RaveKitten13

PostPosted: Sun Aug 20, 2006 8:20 pm


AMT trip reports to come.
PostPosted: Sun Aug 20, 2006 8:23 pm


This is a pretty big family just so you know.

2C-B (4-Bromo-2,5-Dimethoxyphenethylamine): 2C-B is a synthetic psychedelic that first gained popularity as a legal Ecstasy replacement in the mid 1980s. It is known for having a strong physical component to its effects and a moderate duration.

2C-C (2,5-Dimethoxy-4-Chlorophenethylamine): 2C-C is an short-acting synthetic psychedelic. It is uncommon and has only a short history of human use. (This is a Research Chemical: Chemicals marked on Erowid by our Research Chemical Symbol should be considered experimental chemicals. Although some people are willing to ingest these chemicals for their effects, it is not reasonable to assume that these chemicals are in any way 'safe' to use recreationally. Although all psychoactive use involves risk, this class of chemicals has undergone virtually no human or animal toxicity studies and there is little to no data on possible long term problems, addiction potential, allergic reactions, or acute overdoses.

Publication of information by Erowid about human use of these chemicals is not intended to endorse their non-laboratory use. It is important to remember that reactions to psychoactives vary dramatically from person to person. Extrapolating anything from any single person's experience with a chemical is inappropriate and may result in dangerous and possibly fatal abreactions.

Some reports of use may include extremely glowing "wow"-type experiences. Reports of this nature should not be misunderstood to suggest that they are common or typical of those who ingest the substance, or that the effects will be pleasant or desirable.

Users should consider carefully before choosing to work with these substances.)

2C-D (LE-25, 2,5-Dimethoxy-4-Methylphenethylamine):2C-D is an short-acting synthetic psychedelic. It is uncommon and has only a short history of human use. (This is a Research Chemical).

2C-E (2,5-Dimethoxy-4-Ethylphenethylamine): 2C-E is an synthetic psychedelic. It is uncommon and has only a short history of human use. (This is a Research Chemical).

2C-G (2,5-Dimethoxy-3,4-Dimethylphenethylamine): A true psychedelic or insightenhancer with potential value in psychotherapy. Non sexual and slightly anorexic.

2C-G-3 (2,5-Dimethoxy-3,4-(Trimethylene)-Phenethylamine, 5-(2-Aminoethyl)-4,7-Dimethyoxyindane): LSD similiar.

2C-G-5 (3,6-Dimethoxy-4-(2-Aminoethyl)-Benzonorbornane): Similiar to 2C-B and less intense then the 2-C-Ts.

2C-G-N (1,4-Dimethoxynaphthyl-2-Ethylamine): More of an anti-depressent than a psychedelic.

2C-I (2,5-Dimethoxy-4-Iodophenethylamine): 2C-I is an short-acting synthetic psychedelic. It gained some popularity in Europe and the U.S. (2001-2005) though it has only a short history of human use. (is a Research Chemical).

2C-N (2,5-Dimethoxy-4-Nitrophenethylamine): Similiar to MDMA without the anti-stress componant.

2C-P (2,5-Dimethoxy-4-(n)-Propylphenethylamine): Erotic and emotional.

2C-SE (2,5-Dimethoxy-4-Methylseleneophenethylamine): Semi benign.

2C-T (2,5-Dimethoxy-4-Methylthiophenethylamine): Potnetial MDMA subsitute.

2CT-2 (2,5-Dimethoxy-4-Ethylthiophenethylamine): 2C-T-2 is a synthetic psychedelic. It is uncommon and has only a short history of human use. (Research Chemical).

2C-T-4 (2,5-Dimethoxy-4-(i)-Propylthiophenethylamine): 2C-T-4 is a synthetic psychedelic. It is very uncommon and has only a short history of human use. (Research Chemical).

2C-T-7 (2,5-Dimethoxy-4-(n)-Propylthiophenethylamine): 2C-T-7 is a synthetic psychedelic known for its colorful visuals. It experienced a surge in popularity, due to internet sales, during 1999-2001 before being made illegal in the U.S. (Research Chemical).

2C-T-8 (2,5-Dimethoxy-4-Cyclopropylmethylthiophenethylamine): Similar to 2-C-T-2.

2C-T-9 (2,5-Dimethoxy-4-(t)-Butylthiophenethylamine)

2C-T-13 (2,5-Dimethoxy-4-(2-Methoxyethylthio)Phenethylamine): Good to supplement 2-C-T-2 on.

2C-T-15 (SESQUI, 2,5-Dimethoxy-4-Cyclopropylthiophenethylamine): Talkative drug.

2C-T-17 (NIMITZ, 2,5-Dimethoxy-4-(s)-Butylthiophenethylamine): Heavy psychedelic.

2C-T-21 (2,5-Dimethoxy-4-(2Fluoroethylthio)phenethylamine): 2C-T-21 is a synthetic psychedelic. It is very uncommon and has only a short history of human use. (Research Chemical).

And now I have to go down the doses, effects, and whatnot about as many of these as possible

BASICS:

2-C-B (http://www.erowid.org/chemicals/2cb/2cb_basics.shtml)

2C-B is a synthetic psychedelic that first gained popularity as a legal Ecstasy replacement in the mid 1980s. It is generally considered to be somewhat 'gentler' than LSD or mushrooms, being less prone to catalyzing dissociated freak-outs or overwhelming panic attacks at normal recreational doses. 2C-B is also known for the strong body component of its effects which are alternately described as pleasurable energy or a 'sense of being in the body', and by others as an unpleasant 'buzzing' or body-load.

2C-B is still sometimes sold as "ecstasy", although this is rare because it is actively sought by many users for its unique effects. 2C-B is sometimes chosen for use in psychedelic psychotherapy because its short duration and less 'pushy' character.
[ Main 2C-B Vault ]


Dose
A standard oral dose of 2C-B is between 10 and 40 mg. It is most frequently found in either powder or (small) pill form. Pills have commonly contained 5 mg, though this varies. 2C-B is also sometimes snorted for a shorter experience with quicker onset. Snorted doses are about 1/3 that of an oral dose and are legendarily painful. Underground market 2C-B has historically been of high quality because it has generally been sold to a relatively exclusive market of knowledgeable buyers.

Price
2C-B is often sold at ecstasy prices at clubs & parties, from 10-30$ per 'dose' (usually 15-25mg). Purchased in large quantities it sells for 200-500$ per gram at retail levels or 100-300$ per gram at wholesale prices. (August 2000)

Law
2C-B is illegal to possess and sell in the United States (schedule I) and in most other countries. 2C-B was scheduled in the U.S. in 1993 and in most other countries between 1994 and 1998.

Chemistry
4-Bromo-2,5-dimethoxyphenethylamine (2C-B) is a synthetic chemical in the phenethylamine class. It is related structurally to mescaline, DOB, and distantly to MDMA.

History
2C-B was first synthesized by Alexander Shulgin in 1974 while exploring homologues of DOB. Its psychoactivity was first discovered on June 25, 1975 by Dr. Shulgin who described it as "beautifully active". 2C-B was marketed in the late 1980s as an MDMA replacement after Ecstasy was scheduled in 1985. It was added to schedule I in the U.S. in 1994 and by 1999, it was illegal in most of the world.

Slang
The Substance: 2C-B, Nexus, Bees
The Experience: Tripping, To See Bees



EFFECTS

Onset
Depending on how much and how recently one has eaten, oral 2C-B generally takes 45-75 minutes to take effect. On a full stomach, onset can be considerably slower.

Duration
The primary effects of 2C-B last approximately 4-6 hours when taken orally. For many people there is an additional period of time (2-4 hrs) where it is difficult to go sleep but where mood and mind-set are mostly back to baseline. The day-after effects of 2C-B are relatively mild, with most users reporting little to no lingering negative effects.

The Experience
In the beginning stages of onset, 2C-B is likely to cause a sort of indefinable feeling similar to anticipation or anxiety. There may be a feeling of energy in the body, and the sense that things are different than usual. As the effects intensify, a wide variety of perceptual changes may occur; pupil dilation, visual patterning and movement, mental stimulation, new perspectives, feelings of insight, emotional shifts (mood lift or introspection), anxiety and confusion. Many people find that the effects of 2C-B are more subtle or manageable than those of other psychedelics, allowing the user to more easily approach baseline thinking during the experience. Unlike some other psychoactives, many people find themselves able to eat shortly after peak effects subside. Closed-eye visuals are quite common with 2C-B. Open-eye visual patterning, color-shifts, and wavering or moving vision are common for many people and are more likely at higher doses



PROBLEMS
Many users do not enjoy the effects of 2C-B because of its unpleasant body effects or 'body load'. Unpleasant stomach effects, gastro-intestinal distress (diarrhea, cramps & gas) are not uncommon. There are also several reports of allergic type reactions causing increased mucus production, occasionally this results in coughing as mucus gathers in the windpipe and lungs.

Other possible negative effects include anxiety and unwanted or frightening thoughts and visions. 2C-B, though significantly lesser common than with LSD, can precipitate strong, temporary changes in an individual's experience of life and reality. It can be a powerful psychoactive experience, especially at higher doses, which is significantly affected by experiences, set and setting. Recent experiences, especially strong ones, can have a substantial effect on a trip. Physically or psychologically unsettling events in the days before a trip can blossom into more serious distress and trauma while tripping. It is important to be prepared for the possibility of encountering difficult or frightening mental states. The Psychedelic Crisis FAQ addresses some of the issues involved in dealing with a difficult trip.


Addiction Potential
2C-B is neither physically addicting nor likely to cause psychological dependance. As with all substances, some people will use it more frequently than they are comfortable with. There is a short period of tolerance after 2C-B use. Using 2C-B two days in a row is likely to lead to a diminished experience the second day, though spaced 5-7 or more days apart, this effect is nearly non-existent.

Contraindications

Do not take 2C-B if you are currently taking an MAOI. MAOIs are most commonly found in the prescription anti-depressants Nardil (phenelzine), Parnate (tranylcypromine), Marplan (isocarboxazid), Eldepryl (l-deprenyl), and Aurorex or Manerix (moclobemide). Ayahuasca also contains MAOIs (harmine and harmaline). 2C-B and MAOIs are a potentially dangerous combination. Check with your doctor if you are not sure whether your prescription medication is an MAOI.


Do not operate heavy machinery. Do Not Drive.


If you have a seizure or convulsive disorder or heart problems, you may be at higher risk for health problems when taking 2C-B. Diabetics should monitor their blood sugar closely as there have been some reports of problems.


Individuals currently in the midst of emotional or psychological upheaval in their everyday lives should be careful about choosing to use psychedelics such as 2C-B as they can trigger even more difficulty.


Individuals with a family history of schizophrenia or early onset mental illness should be extremely careful because psychedelics have been known to trigger latent psychological and mental problems.

2-C-I (http://www.erowid.org/chemicals/2ci/2ci_basics.shtml)

2C-I is a phenethylamine somewhat similar in effects to 2C-B. It became available on the grey markets in 2002, but distribution dropped off after a series of DEA busts in 2004 and the prosecutions of vendors selling research chemicals for recreational use. It is available primarily in powder form--though some pressed tablets have been seen--and is generally taken orally. [ Main 2C-I Vault ]


Dose
A standard oral dose of 2C-I is between 10-25 mg. Recent reports suggest that 2C-I is just slightly more potent than 2C-B (slightly less material needed for the same level of effects).

Law
2C-I is an uncontrolled substance in the United States meaning that possession is not specifically illegal. It is possible that possession and sales could be prosecuted under the Federal Analog Act though we are unaware of any such existing cases. 2C-I is scheduled in Germany and Denmark, but not in the European Union (EU).

Chemistry
2,5-Dimethoxy-4-Iodophenethylamine (2C-I) is a synthetic chemical phenethylamine related structurally to 2C-B.

Production
The bulk of available 2C-I is primarily produced by experienced chemists in commercial labs.

History
2C-I first gained public awareness after the publication of PiHKAL by Alexander & Ann Shulgin.

Slang
The Substance: 2C-I
The Experience: tripping



EFFECTS

Onset
Depending on how much and how recently the user has eaten, oral 2C-I takes between 45-75 minutes to take effect. On a full stomach, onset can be considerably slower.

Duration
The primary effects of 2C-I last approximately 5-8 hours when taken orally.



PROBLEMS

Contraindications

Do not take 2C-I if you are currently taking an MAOI. MAOIs are most commonly found in the prescription anti-depressants Nardil (phenelzine), Parnate (tranylcypromine), Marplan (isocarboxazid), Eldepryl (l-deprenyl), and Aurorex or Manerix (moclobemide). Ayahuasca also contains MAOIs (harmine and harmaline). 2C-I and MAOIs are a potentially dangerous combination. Check with your doctor if you are not sure whether your prescription medication is an MAOI.


Do not operate heavy machinery. Do Not Drive.


Individuals currently in the midst of emotional or psychological upheaval in their everyday lives should be careful about choosing to use psychedelics such as 2C-I as they can trigger even more difficulty.


Individuals with a family history of schizophrenia or early onset mental illness should be extremely careful because psychedelics have been known to trigger latent psychological and mental problems.

2-C-T-7 (http://www.erowid.org/chemicals/2ct7/2ct7_basics.shtml)

2C-T-7 is a psychedelic phenethylamine developed by Alexander Shulgin around 1980. The effects of 2C-T-7 share some general similarities with LSD & 2CB, with its length of action more like that of LSD. A research chemical market has recently been created around its recreational, therapeutic, and entheogenic uses. While most of the chemicals in its class are not known to cause acute physical dangers, 2C-T-7's safety profile for wide use is not well known nor researched. As with all new chemicals, it is difficult to be certain what the variety of reactions to the substance will be and the reports of use so far have a lot of conflicting and confusing elements, including duration, physical stimulation, dosage, etc.


Dose
A standard oral dose of 2C-T-7 is between 10 - 50 mg. It is generally found in powder form although it is also produced and sold in pill format, most recently at 7 mg per tablet. Insufflated doses are considerably lower. Users should be extremely careful with dosages as 2C-T-7 can cause unexpected delerium and dissociation at high doses.
Price
Rare, but sometimes sold at parties for 5-20$ per dose, available from exotic chemical suppliers for 375-450$ per gram, about the same from underground suppliers. (August 2000)

Law
2C-T-7 is was placed in Schedule I by emergency order of the DEA on September 20, 2002. This makes it illegal to buy, sell, or possess in the United States without a DEA license. Although Sweden controls 2C-T-7, we are not aware of any other countries that specifically list it as illegal to possess or sell.

Chemistry
2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) is a synthetic chemical in the phenethylamine class. It is related structurally to 2C-B and Mescaline.

History
2C-T-7's chemistry was first published in Alexander Shulgin's book PiHKAL in 1991. It was produced underground in college labs and by small commercial research labs until the late 1990's when it began being produced and sold commercially around the world.

Slang
The Substance: 2C-T-7, T7, Beautiful
The Experience: tripping



EFFECTS

Onset
Depending on how much and how recently one has eaten, 2C-T-7 generally takes 1-2.5 hours to take effect. On a full stomach, onset can be considerably slower than normal.

Duration
2C-T-7's primary effects can last as long as 10-12 hours, with after effects for another 4-6 hours.

The Experience
2C-T-7's effects are unique but classically psychedelic, with some general similarities to LSD & 2C-B. 2C-T-7's effects can include psychedelic visuals (patterning, light sensitivity, color enhancement, etc), mood lift, empathogenesis, anxiety or calmness, emotional volatility, increased sociability, associative / psychedelic ideation, etc. Some users have report unexpected and disconcerting dissociation at high doses. Relatively prominent visuals are common with 2C-T-7 and at higher doses the visuals can overwhelm the visual field creating a 'psychedelic soup'.



PROBLEMS
The most common problems reported by 2C-T-7 users appear to be nausea, vomiting, unpleasant dissociation, and overwhelming visuals at high doses. As with most psychedelics, there is also the possibility of anxiety or panic attacks. In a few higher dose cases, severe dissociation has been reported where the user experienced loss of memory, mental confusion, and extreme inability to deal with real-world situations while fully physically functional. Some reports include the user becoming unusually enraged and violent. This can lead to potentially dangerous situations if an individual is left unsupervised. Heavy dissociation and vomiting can be a life-threatening combination. At least 3 deaths have been reported (April 2001).


Fatalities / Toxicity
There have been 3 deaths which have been tied directly to 2C-T-7. The exact mechanism of death is not yet known, but it is beginning to appear that some direct pharmacological effect may be responsible (rather than an indirect effect such as aspirating vomit). There have been no formal evaluations of the Toxicity of 2C-T-7 that we're aware of.

Addiction Potential
2C-T-7 is neither physically addicting nor likely to cause psychological dependance. As with all substances, some people will use it more frequently than they are comfortable with. There is a short period of tolerance after 2C-T-7 use. Using 2C-T-7 two days in a row is likely to lead to a diminished experience the second day, though spaced 5-7 or more days apart, this effect is nearly non-existent.

Contraindications

Do not take 2C-T-7 if you are currently taking an MAOI. MAOIs are most commonly found in the prescription anti-depressants Nardil (phenelzine), Parnate (tranylcypromine), Marplan (isocarboxazid), Eldepryl (l-deprenyl), and Aurorex or Manerix (moclobemide). Ayahuasca also contains MAOIs (harmine and harmaline). 2C-T-7 and MAOIs are a potentially dangerous combination. Check with your doctor if you are not sure whether your prescription medication is an MAOI.


Do not operate heavy machinery. Do Not Drive.


If you have a seizure or convulsive disorder or heart problems, you may be at higher risk for health problems when taking 2C-T-7. Diabetics should monitor their blood sugar closely as there have been some reports of problems.


Individuals currently in the midst of emotional or psychological upheaval in their everyday lives should be careful about choosing to use psychedelics such as 2C-T-7 as they can trigger even more difficulty.


Individuals with a family history of schizophrenia or early onset mental illness should be extremely careful because psychedelics have been known to trigger latent psychological and mental problems.

EFFECTS:

2C-B (http://www.erowid.org/chemicals/2cb/2cb_effects.shtml)

The effects of 2C-B have been described as a cross between the effects of LSD and MDMA, but that it is nothing like a combination of the two. It is mildly psychedelic, much less mind-expanding or disassociative than mushrooms or LSD, but much less directed than MDMA.

2C-B includes Open Eye Visual (OEV) effects which are usually described as crawling, shifting, or undulating, or cartooning. Closed Eye Visuals (CEVs) are present and increase with dosage. Many report a 'color shift' where objects seem to have red / green halos around them.

2C-B has a large 'body' component which some describe as "body tripping." Shulgin and others say that 2C-B can bring body-issues forward or make them more prominent and, in this way, some people say it can be a self-diagnostic tool for body work. Many, but not all, people experience stomach discomfort sometimes including mild diarhea, gas, nausea and (rarely) vomiting. One user has reported a very a recurrent effect of increased mucus production at the base of the trachea, causing constant coughing during the effects of 2c-b, pseudoephedrine seems to clear this up.

In general, 2C-B has a somewhat 'positive' mood push as well as a mild stimulant effect, but it is far less stimulating and far less forcefully positive than MDMA. Some people find they can sleep once the peak is over (about 60-90mins after the effects start).

Most people experience 2C-B as being much 'lighter' on their body than MDMA with far less 'crash' and much less physically draining. It is also not as 'easy' as MDMA, in that it is more of a 'true' psychedelic -- allowing the users mind to become manifest and create the experience instead of being 'pushed' into a positive mood space as MDMA usually does.

Some people find the stimulating and body effects to combine in a way that is sensual or sexual and Shulgin has said that if an effective aphrodisiac is every discovered, it will probably be patterned after 2C-B. Many people, however, find it very un-sexy with the body effects being experienced as somewhat disquieting.

Some people find 2C-B increases their ability to communicate verbally, while others find themselves unable to elucidate their ideas clearly. Some people describe a type of confusion that can be part of the experience, a type of 'stoned' feeling of mental and physical relaxation or floppiness which can translate in inability or lack of desire to go into complex intellectual processes.

2C-B at medium and low doses has the interested character that it is often quite easy to move into and out of -- that going from feeling very involved in the experience to feeling quite 'sober' can be very fast and sometimes unexpected. Some people describe 2C-B as being more 'plastic' or 'malleable' than other psychedelics because one can learn to manipulate the depth of the effects.

2C-B can be used in some of the same ways MDMA is used for working through interpersonal issues and dealing with emotional conflicts.

'Inappropriate' smiling or giggling is common with 2C-B and other psychedelics.

As with all psychedelics, many people experience the coming up period as being somewhat cold and shivery.

As dose increases, the chance for feelings of fear and uncertainty increase.

As with other entheogens, it is unsafe to drive or use dangerous equipment with 2C-B because it effects attention span, visual acuity, concentration, and coordination. If you work with 2C-B, plan your entheogen experiences carefully and think ahead so you don't ever find yourself needing to drive during the experience.

2C-C (http://www.erowid.org/chemicals/2cc/2cc_effects.shtml)

2C-C is a psychedelic phenethylamine, with dosage and effects similar, but not identical, to those of 2C-B. Some users report similarities with other psychedelics such as LSD.

2C-E (http://www.erowid.org/chemicals/2ce/2ce_effects.shtml)

POSITIVE
sense of well-being (enhanced lucidity, sense of inner peace)
increase in energy (stimulation)
increase in associative & creative thinking
increased awareness and appreciation of music
increased awareness of senses
increased tactile sensations
visual patterning, closed and open eye visuals
insight into personal issues
profound life-changing spiritual experiences
NEUTRAL
general change in consciousness (as with most psychoactives)
pupil dilation
difficulty focusing, restlessness
change in perception of time
slight increase in body temperature
slight increase in heart rate
NEGATIVE
muscle tension and aching
jaw tension
increased perspiration
gastrointestinal discomfort, nausea and vomiting
dizziness, confusion
over-awareness & over-sensitization to music and noise
paranoia, fear
unwanted life-changing spiritual experiences
possible difficulty integrating experiences

2C-T-7 (http://www.erowid.org/chemicals/2ct7/2ct7_effects.shtml)

POSITIVE
sense of well-being (enhanced lucidity, sense of inner peace)
emotional opening
significant closed and open eye visuals
increased appreciation of music
NEUTRAL
general change in consciousness (as with most psychoactives)
pupil dilation
change in perception of time
visual hallucinations
aural hallucinations
NEGATIVE
nausea and vomiting
muscle tension
irritating body load
muscle tremors and/or convulsions
memory loss (at higher doses)
delerium (at higher doses) (potentially dangerous)
violent behavior (at higher doses)
death

2C-T-7 Overdoses & Delerium #
A handful of reports of 2C-T-7 overdoses (non life threatening) have come through in the last 4 months and it is extremely important to realize that 2C-T-7 is a powerful psychedelic with a dose-response profile that makes it very easy to take way too much. Some users have recently reported either taking themselves to the hospital or being taken to the emergency room from 2C-T-7 alone. Users who have taken as little as 10mg orally have reported being overwhelmed with anxiety and discomfort, while some users who have snorted 15mg or taken 30mg or more orally report being completely overwhelmed by the intensity of the experience. These users report becoming frightened for their health, completely dissociated (forgetting who they are, where they are, that they've ingested a chemical), experiencing intense and frightening body pains (stomach & muscle cramps), becoming unable to see because of the intensity of the visuals, becoming beligerent, etc. This is especially worrisome with 2C-T-7 because the effects last so long and high dose users often wander around and get themselves in trouble in public by being completely incapable of taking care of themselves.

Many users of 2C-T-7 are most familiar with the effects of ecstasy and it's very important to realize that 2C-T-7 is very unlike ecstasy and can often lead to difficult, intense, and overwhelmingly confusing experiences which are much safer and more useful when taken in a safe, private context with a sitter or therapist. This is not ecstasy. Please be extremely careful with this research chemical, measure it very carefully, and do not eyeball doses.



Notes on Snorting 2C-T-7 (Not Recommended) #
There's been quite a bit of discussion about snorting 2C-T-7 partially because of the reported deaths in combination with some of the dramatic and severe overdose reactions people have had. In Erowid's Fall 2000 2C-T-7 survey, conducted by Murple, one surprising result was that people reported that they snorted 2C-T-7 in order to reduce side effects, but actually ended up experiencing greater side effects, on average, than people who ingested it orally (see Murple's writeup).

Using the pure powdered 2C-T-7 causes most users intense discomfort and is very likely to be bad for the sinuses. As with other snortables, this will lead to more serious problems if used chronicly. Unlike Cocaine or Ketamine, 2C-T-7 causes intense burning pain which lasts 5-15 minutes before it begins to fade, leaves an unpleasant drip that permeates the experience, and can lead to sinus and throat infections in some people. This is similar to the experiences reported when other 2C- compounds are snorted. Most users contacted by Erowid said they would not repeat snorting 2C-T-7 because of the increased side effects and accidental overdoses.

DOSES and DURATION (finally they all come out again).

2C-B (http://www.erowid.org/chemicals/2cb/2cb_dose.shtml)

Threshold 2 - 5 mg
Light 5 - 15 mg
Common 10 - 25 mg
Strong 20 - 50 mg

4-8 hours

2C-C (http://www.erowid.org/chemicals/2cc/2cc_dose.shtml)

Threshold unknown
Light 15 - 25 mg
Common 25 - 35 mg
Strong 35 - 55 mg

Onset :
Duration : 3 - 5 hours

2C-D (http://www.erowid.org/chemicals/2cd/2cd_dose.shtml)

Threshold 3 - 4 mg
Common 20 - 50 mg
Strong 50 - 100 mg

Onset : 30 - 120 minutes (depending on form and stomach contents)
Duration : 3 - 6 hours

2C-E (http://www.erowid.org/chemicals/2ce/2ce_dose.shtml)

Threshold 2 - 5 mg
Light 5 - 10 mg
Common 10 - 15 mg
Strong 15 - 20 mg
Heavy 20 - 25 mg

Onset : 20 - 90 minutes (depending on form and stomach contents)
Duration : 6 - 10 hours
Normal After Effects : 2 - 6 hours

2C-G

Dose: 20-35 mg
Duration: 18-30 hours

2C-G-3

Dose: 16-25 mg
Duration: 12-24 hours

2C-G-5

Dose: 10-16 mg
Duration: 32-48 hours

2C-G-N

Dose: 20-40 mg
Duration: 20-30 hours

2C-I (http://www.erowid.org/chemicals/2ci/2ci_dose.shtml)

Threshold 2 - 5 mg
Light 5 - 15 mg
Common 10 - 25 mg
Strong 20 - 30 mg

Duration: 6-10 hours

2C-N

Dose: 100-150 mg
Duration: 4-6 hours

2C-P

Dose: 6-10 mg
Duration: 10-16 hours

2C-SE

Dose: about 100 mg
Duration: 6-8 hours

2C-T

Dose: 60-100 mg
Duration: 3-5 hours

2C-T-2 (http://www.erowid.org/chemicals/2ct2/2ct2_dose.shtml)

Threshold 5 mg
Light 10 - 15 mg
Common 16 - 32 mg
Strong 32 - 48 mg

Duration: 6-8 hours

2C-T-4

Dose: 8-20 mg
Duration: 12-18 hours

2C-T-7 (http://www.erowid.org/chemicals/2ct7/2ct7_dose.shtml)

Threshold 3 - 5 mg
Light 10 - 20 mg
Common 15 - 30 mg
Strong 10 - 50 mg
Heavy 25 - 60 mg

Onset : 20 - 140 minutes
Duration : 6 - 12 hours
Normal After Effects : up to 12 hours

2C-T-8

Dose: 30-50 mg
Duration: 10-15 hours

2C-T-9

Dose: 60-100 mg
Duration: 12-18 hours

2C-T-13

Dose: 25-40 mg
Duration: 6-8 hours

2C-T-15

Dpse: greater then 30 mg
Duration: Several hours

2C-T-17

Dose: 60-100 mg
Duration: 10-15 hours

2C-T-21

Dose: 8-12 mg
Duration: 7-10 hours

LAW

2C-B

USA: Schedule I
Australia #
2C-B is controlled in Australia and is also on the list of substances subject to import and export controls. See Australian Psychoactive Law.
Appendix B: Substances Subject to import and export controls
Estonia #
2C-B is Schedule I [reference] (Thanks tjj).
E.U.#
The U.N. Narcotics Commission added 2C-B to Schedule II in March 2001.
Canada#
Schedule III. Listed as 4--bromo--2,5--dimethoxybenzeneethanamine.
Japan#
Scheduled Summer 1998. Until that time it was marketed as a sexual aid named "Performax".
Netherlands#
Scheduled as a hard drug on July 9th, 1997.
Norway #
Schedule II as of March 22, 2004. Listed as 4-bromo-2,5-dimethoxyphenethylamine. Norwegian Law Reference: http://www.lovdata.no/ltavd1/lt2004/t2004-1-05-39.html (Thanks R.A.S.)
Poland #
2C-B is schedule I (I-P group) in Poland. (No Reference)
Sweden#
2C-B was placed in schedule I in Sweden on Jun 13, 2002. It was first regulated April 1, 1999 through a new law, concerning "Compounds dangerous to ones health", a type of "emergency scheduling". Swedish Law Reference.
Switzerland#
2C-B controlled in Switzerland as of 1/1/2002 (no reference).
U.K.#
2C-B is Schedule I in the U.K., making it illegal to sell, buy, or possess without a license.

2C-C

Unscheduled but possible illegal due to the Analog Act

Sweden #
AMT, 2C-C, 2C-D, 4-AcO-DIPT, and 4-HO_DIPT were controlled as of March 1, 2005. See Statens Folkhaelsoinstitut.

2C-D

Possible Analog

2C-E

Possible Analog

Sweden #
Controlled in Sweden as of Oct 1, 2004

2C-I

Possible Analog

Australia #
The National Drugs and Poisons Schedule Committee has a draft document which suggests it will probably formally add 2C-I, 2C-T-2, 2C-T-7, and 5-MeO-AMT to the list of controlled substances in australia sometime in 2005. See NDPSC Pre-February 2005 Scheduling Meeting Notice. (Thanks Grantos) Additionally, in response to a specific question regarding the current legal status of 2C-I, Australian authorities recently wrote that 2C-I is already covered by schedule 9 under the entry for "Alkoxyphenylethylamines and substituted..". (Thanks NH)
Belgium #
2C-I was added to the list of illegal psychotropic substances on Nov 8, 2004 [Moniteur Belge/Belgisch Staatsblad].
Denmark #
2C-I is reportedly illegal in Denmark as of May 2002 : ('Bekendtg0relse nr 305 af 16. maj 2002 om aendring af bekendtg0relse om euforserende stoffer') [link].
E.U. #
EU Council published an order on Dec 6 2003, asking all member states to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2 within 90. See Final Rule here. This binding order went against a non-binding EU Commission's recommendation from earlier in 2003. The Commission did not recommend controlling these chemicals because of lack of evidence of problems: Commission of the European Communities : Report from the Comission to the Council : TMA-2, 2C-I, 2C-T-2, and 2C-T-7.
France #
2C-I was added to the list of controlled substances in August 2004 as a "synthetic other" of mescaline. [Reference]
Germany #
2C-I is schedule I (Highest level of control). It can not be prescribed, manufactured, or possessed as of Sep, 1999 (listed as 4-Iod-2,5-dimethoxyphenetylazan). See Deutsche BtMG.
Finland #
Finland is moving to control 2C-I, TMA-2, 2C-T-2, and 2C-T-7 despite these being extremely rare in Finland. The recommendation can be found at: eduskunta.fi (Thanks H)
Greece #
2C-I is illegal to possess in Greece: Table A of Law 1729/87.
Ireland #
2C-I is illegal to possess in Ireland (Schedule 1) according to the EMCDDA.
Italy #
2C-I was added to the "Tabella 1" (list of prohibited plants and substances) in a Jan 11, 2005 Ministry of Health statement. (Text of Jan 11 2005 decree: Gazzetta Ufficiale N. 54 del 07 Marzo 2005; text of Jun 2004 ordinance) (Thanks Xochi, AG, GBH)
Japan #
We received word that in April, 2005, Japan added 2C-I, MBDB, and 5-MeO-DIPT to the list of controlled substances, however we've been unable to completely confirm this. A vendor site claims this to be true, but we have not been able to locate any official documents about this. (Thanks Strange Reality)

2C-I was not listed in the Japanese list of controlled substances as of May, 2003. However the Tokyo metropolitan government notes: "2c-i is an analogue of Japanese illegal drug called 2c-B, and we think 2c-i would be psychedelic hallucinogen." And says, "We call these substances not 'legal-drug' but 'deviated-from-law-drug'." metro.tokyo.jp [unconfirmed, thank to AcQuio]
New Zealand #
New Zealand has a catch-all Analogues section in Schedule 3 / Class C of their drug laws that would probably make 2C-I a Schedule 3 compount in New Zealand. See for more information about this.
Portugal #
Portugal enacted a law in January 2005 to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2. (Thanks PL) See policiajudicia.pt : law changes and Psychoactives Law : Portugal
Sweden #
2C-I is illegal to possess in Sweden (Class I) as of March 16, 2004 (mpa.se). (Thanks WP)
U.K. #
2C-I is controlled as a Class A drug under the broad Misuse of Phenethylamines Act.

2C-T-2

Possible Analog

Australia #
The National Drugs and Poisons Schedule Committee has a draft document which suggests it will probably formally add 2C-I, 2C-T-2, 2C-T-7, and 5-MeO-AMT to the list of controlled substances in australia sometime in early 2005. See NDPSC Pre-February 2005 Scheduling Meeting Notice. (Thanks Grantos).
Belgium #
2C-T-2 was added to the list of illegal psychotropic substances on Nov 8, 2004 [Moniteur Belge/Belgisch Staatsblad].
Denmark #
2C-T-2 was added to category B of the controlled substances list on August 23, 2003. (text of law)
Germany #
List I / Highest level of control, unable to be prescribed, manufactured, or possessed as of Oct 7, 1998. (listed as 4-Ethylsulfanyl-2,5-dimethoxyphenethylazan) -- http://jurcom5.juris.de/bundesrecht/btmg_1981/anlage_i_58.html.
E.U. #
EU Council published an order on Dec 6 2003, asking all member states to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2 within 90. See Final Rule here. This binding order went against a non-binding EU Commission's recommendation from earlier in 2003. The Commission did not recommend controlling these chemicals because of lack of evidence of problems: Commission of the European Communities : Report from the Comission to the Council : TMA-2, 2C-I, 2C-T-2, and 2C-T-7.
Finland #
Finland is moving to control 2C-I, TMA-2, 2C-T-7, and 2C-T-2. The recommendation can be found at: eduskanta.fi (Thanks H)
Italy #
2C-T-2 was added to the "Tabella 1" (list of prohibited plants and substances) in a Jan 11, 2005 Ministry of Health statement. (Text of Jan 11 2005 decree: Gazzetta Ufficiale N. 54 del 07 Marzo 2005; text of Jun 2004 ordinance) (Thanks Xochi, AG, GBH)
Netherlands #
Classified as an unregistered pharmaceutical as of April 12, 1999. Unlicensed manufacture, sale, import, trade and possession of this substance can be prosecuted.
Portugal #
Portugal enacted a law in January 2005 to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2. (Thanks PL) See policiajudicia.pt : law changes and Psychoactives Law : Portugal
Sweden #
2C-T-2 was first regulated April 1, 1999 at which time it was not scheduled, but regulated through a new law, concerning "Compounds dangerous to ones health" (Reference). It was then added to Class I as of March 16, 2004. (Thanks WP)

2C-T-4

Possible Analog

Denmark #
2C-T-4, TFMPP, BZP, mCPP, and MeOPP were all banned in Denmark as of Dec 3 2005. See Denmark bans 2C-T-4, BZP, and other Chemicals. Thanks to S.
Sweden #
We've been told that 2C-T-4 is uncontrolled in Sweden (Unconfirmed)

2C-T-7

Schedule I

Australia #
The National Drugs and Poisons Schedule Committee has a draft document which suggests it will probably formally add 2C-I, 2C-T-2, 2C-T-7, and 5-MeO-AMT to the list of controlled substances in australia sometime in early 2005. See NDPSC Pre-February 2005 Scheduling Meeting Notice. (Thanks Grantos)
Austria #
2C-T-7 not controlled in Austria, see Austrian Schedules or http://www.ris.bka.gv.at/bgbl/ (in German).
Belgium #
2C-T-7 was added to the list of illegal psychotropic substances on Nov 8, 2004 [Moniteur Belge/Belgisch Staatsblad].
Denmark #
2C-T-7 was added to category B of the controlled substances list on August 23, 2003. (text of law)
E.U. #
E.U. Council published an order on Dec 6 2003, asking all member states to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2 within 90. See Final Rule here. This binding order went against a non-binding EU Commission's recommendation from earlier in 2003. The Commission did not recommend controlling these chemicals because of lack of evidence of problems: Commission of the European Communities : Report from the Comission to the Council : TMA-2, 2C-I, 2C-T-2, and 2C-T-7.
Finland #
Finland is moving to control 2C-I, TMA-2, 2C-T-7, and 2C-T-2. The recommendation can be found at: eduskanta.fi (Thanks H)
Germany #
List I / Highest level of control, unable to be prescribed, manufactured, or possessed as of Oct 7, 1998. (listed as 2,5-Dimethoxy-4-(propylsulfanyl) phenethylazan) http://jurcom5.juris.de/bundesrecht/btmg_1981/anlage_i_58.html.
Greece #
2C-T-7 became a controlled substance in Greece on Feb 18, 2003 [EU Legal Database].
Italy #
2C-T-7 was added to the "Tabella 1" (list of prohibited plants and substances) in a Jan 11, 2005 Ministry of Health statement. (Text of Jan 11 2005 decree: Gazzetta Ufficiale N. 54 del 07 Marzo 2005; text of Jun 2004 ordinance) (Thanks Xochi, AG, GBH)
Japan #
2C-T-7 is not controlled in Japan as of May 1, 2005. (Unconfirmed) (Thanks AVR)
Portugal #
Portugal enacted a law in January 2005 to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2. (Thanks PL) See policiajudicia.pt : law changes and Psychoactives Law : Portugal
Sweden #
2C-T-7 was first regulated April 1, 1999 at which time it was not scheduled, but regulated through a new law, concerning "Compounds dangerous to ones health" (Reference). It was then added to Class I as of March 16, 2004 (mpa.se). (Thanks WP)

2C-T-21

Possible Analog

Information on the other 2C's is unavailable however it is also possible they would be considered analogs.

RaveKitten13


RaveKitten13

PostPosted: Sun Aug 20, 2006 8:24 pm


2C* Trip Reports.
Reply
Guides/Factual Information

 
Manage Your Items
Other Stuff
Get GCash
Offers
Get Items
More Items
Where Everyone Hangs Out
Other Community Areas
Virtual Spaces
Fun Stuff
Gaia's Games
Mini-Games
//
//

// //

Have an account? Login Now!

//
//